[18F]MK-6240 PET (where MK-6240 is 6-(fluoro)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine) is used to assess in vivo tau deposition across the Alzheimer disease (AD) spectrum. We aimed to quantify the associations and bias of early-frame [18F]MK-6240 PET as surrogates for cerebral perfusion against gold standard [15O]water PET and the potential impact of cerebral perfusion on [18F]MK-6240 tau quantification across aging and the AD spectrum. Methods: Fourteen cognitively normal (CN, 4 young CN and 10 old CN) and 3 AD participants underwent dynamic [18F]MK-6240 PET, with 9 undergoing arterial sampling. A subset (n = 11) underwent [15O]water PET. [18F]MK-6240 perfusion indices were estimated as radiotracer delivery indices K 1 (using 2-tissue-compartment models), and relative perfusion indices were estimated as R1 (using compartmental and reference tissue models, cerebellar gray matter reference region) and early-frame SUV ratio (0-3 min). [15O]water K 1 and R1 were estimated using 1-tissue-compartment models). [18F]MK-6240 tau burden was estimated using distribution volume ratio and SUV ratio at 90-110 min. Spearman correlations, linear mixed-effect models, and Bland-Altman analyses examined relationships between [18F]MK-6240 perfusion indices against [15O]water and between estimates of perfusion and tau burden in tau-relevant regions. The impact of partial-volume correction was examined. Results: Significant correlations were observed between [18F]MK-6240 K 1 and [15O]water K 1 (ρ = 0.57); However, [18F]MK-6240 K 1 underestimated [15O]water K 1 by up to 50%, with a strong negative proportional bias. Significant correlations were observed between [18F]MK-6240 relative perfusion and [15O]water R1 (ρ > 0.84), with minimal bias. In 2 AD participants, significant correlations were observed between perfusion and [18F]MK-6240 retention. Applying partial-volume correction did not significantly impact the correlations or improve the underestimations in [18F]MK-6240 K 1 Conclusion: Using head-to-head [18F]MK-6240 and [15O]water data, we showed that [18F]MK-6240 exhibited a relatively low extraction fraction, leading to underestimation of cerebral perfusion. Our results provide further support for [18F]MK-6240 R1 as a reliable estimate of relative cerebral perfusion, with strong associations and minimal bias compared with [15O]water. In addition, lower perfusion may be associated with higher [18F]MK-6240 retention in tau-relevant regions in AD. These findings further support the use of dynamic [18F]MK-6240 in dual-imaging assessments of tau burden and vascular health.
Keywords: PET; [18F]MK-6240; perfusion; tau.
© 2025 by the Society of Nuclear Medicine and Molecular Imaging.